293780AptaBio Therapeutics293780 info
$6.48info-5.29%24h
Global rank19249
Market cap$144.40M
Change 7d-
YTD Performance-9.77%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    AptaBio Therapeutics (293780) Stock Overview

    AptaBio Therapeutics Inc. discovers and develops selective inhibitors of the NOX family of enzymes and aptamer-based anti-cancer drugs. The company offers Lipofector-Q, Lipofector-EXT, Lipofector-2000, Lipofector-EZ, and Lipofector-pMAX Reagent for transfecting DNA or RNA into eukaryotic cells. Its product candidates include PX-115 for treating diabetic nephropathy; APX-1004 to treat diabetic retinopathy; and APX-311 for use in treating non-alcoholic steatohepatitis (NASH). The company was founded in 2009 and is based in Yongin-Si, South Korea.

    293780 Stock Information

    Symbol
    293780
    Address
    Tower 504, 13Yongin-si, 16954South Korea
    Founded
    -
    Trading hours
    -
    Website
    https://www.aptabio.com
    Country
    🇰🇷 South Korea
    Phone Number
    82 70 7152 0097

    AptaBio Therapeutics (293780) Price Chart

    -
    Value:-

    AptaBio Therapeutics Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $6.48
    N/A
    Market Cap
    $144.40M
    N/A
    Shares Outstanding
    22.30M
    N/A
    Employees
    0
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org